Want to join the conversation?
$ANGO saw growth in the Peripheral Vascular franchise in 1Q17 due to the opportunities created by its competitor's (Cook Medical) recall of its angiographic products. Across the business, $ANGO also delivered good performance in BioFlo Midline and Dialysis in the Vascular Access franchise and growth for NanoKnife and Microwave in Oncology/Surgery.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?